Renalytix Plc
RENXF
$0.091
-$0.039-30.00%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 2.35M | 2.29M | 2.22M | 2.41M | 2.89M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 2.35M | 2.29M | 2.22M | 2.41M | 2.89M |
Cost of Revenue | 2.05M | 2.13M | 2.26M | 2.26M | 2.49M |
Gross Profit | 299.00K | 156.00K | -35.00K | 152.00K | 404.00K |
SG&A Expenses | 17.06M | 19.84M | 21.70M | 24.96M | 26.43M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 26.44M | 31.17M | 35.52M | 40.49M | 42.29M |
Operating Income | -24.09M | -28.89M | -33.29M | -38.08M | -39.40M |
Income Before Tax | -28.02M | -33.45M | -37.48M | -41.84M | -43.81M |
Income Tax Expenses | 6.00K | 4.00K | 8.00K | 7.00K | 3.00K |
Earnings from Continuing Operations | -28.03 | -33.46 | -37.49 | -41.85 | -43.81 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -28.03M | -33.46M | -37.49M | -41.85M | -43.81M |
EBIT | -24.09M | -28.89M | -33.29M | -38.08M | -39.40M |
EBITDA | -23.79M | -28.52M | -32.97M | -37.69M | -38.95M |
EPS Basic | -0.26 | -0.32 | -0.39 | -0.45 | -0.51 |
Normalized Basic EPS | -0.14 | -0.17 | -0.21 | -0.26 | -0.28 |
EPS Diluted | -0.27 | -0.33 | -0.40 | -0.46 | -0.51 |
Normalized Diluted EPS | -0.14 | -0.17 | -0.21 | -0.26 | -0.28 |
Average Basic Shares Outstanding | 438.78M | 427.85M | 383.43M | 371.34M | 348.96M |
Average Diluted Shares Outstanding | 438.78M | 427.85M | 383.43M | 371.34M | 348.96M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |